Clinical trials

Why Queensland is the Ideal Destination for Clinical Trials and Medical Innovation

Queensland offers a unique combination of a robust regulatory and tax environment, access to world-class researchers and clinicians, and cutting-edge infrastructure, making it an ideal location for prototyping, testing, conducting clinical trials, and manufacturing.

By choosing Queensland, you can significantly enhance the speed of your product research and development. Leveraging southern hemisphere sites allows for year-round recruitment of patients with seasonal ailments such as influenza and allergies, as well as those diagnosed with respiratory and tropical diseases. This unique advantage ensures faster trial completion and more comprehensive data collection.

Queensland conducts many clinical trials annually across hundreds of sites statewide. In 2025 alone, Queensland Health facilitated approximately 400 new clinical trials, reinforcing its position as a large provider of clinical trials across the state and spanning a diverse range of therapeutic areas.

Queensland Health has developed a connected clinical trial network that eliminates geography as a barrier to participation in clinical trials and research overall, ensuring that patients in metropolitan, regional, rural, and remote areas have equitable access to cutting-edge medical research. By building on regional infrastructure, fostering both local and global partnerships, and integrating digital health technologies, Queensland’s decentralised model is advancing healthcare innovation and addressing health inequities. This scalable approach has proven its ability to deliver clinical trials across diverse geographies, optimising recruitment, reducing patient travel, and enhancing workforce capacity and confidence in regional and remote areas. The model stands as a blueprint for decentralised trials globally, offering a sustainable and adaptable solution for expanding access to clinical research.

Queensland is internationally recognised for its highly skilled clinical workforce and the exceptional quality of research data produced by its experienced teams. The state is home to a comprehensive ecosystem of support services, including:

• Contract research organisations (CROs)
• Health economics, financial, and legal services
• Imaging and genomic facilities
• Laboratory services
• Good Manufacturing Practice (GMP) manufacturers
• Regulatory consultants

This integrated network ensures that companies have access to the resources needed to bring their innovations to market efficiently and effectively.

Queensland is part of a nationwide approach that embraces fast and pragmatic regulatory pathways for clinical trials. The Clinical Trials Notification (CTN) scheme, administered by the Therapeutic Goods Administration (TGA), enables rapid trial start-up through streamlined processes. Importantly, Australian clinical trial data is accepted by major international regulatory agencies, including the United States Food and Drug Administration (FDA) and the European Medicines Agency (EMA), ensuring global relevance and market access.

There has never been a better time to invest in Queensland. With its unmatched combination of expertise, infrastructure, and regulatory efficiency, Queensland offers a compelling opportunity for companies looking to advance their medical innovations and clinical research. Make the decision to partner with Queensland today.